zanubrutinib,zandelisib,rituximab
beigene,mei,kyowa kirin
['mantle,(-dismantle)', 'equate', 'zandelisib', 'follicular', 'ritux', 'zanubrutinib', 'lymphoma', 'lymsm', 'imab ']
#ash22 #lymsm #mcl
soumerai et al zandelisib+zanubrutinib in rr mcl/fl
pi3kd inhibitor fl 31, mcl 19 pts
fl orr 86.7% cr 23.3% pfs 22.4 mo
mcl orr 72.7% cr 29% pfs 10.1 mo i think we need to stop doing btki studies in fl
in mcl, combo activity same as sa btki 
Clinician-researcher-educator bookworm @RoswellPark. Passionate about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews